Join our 20.000 subscribers and receive the monthly newsletter for free!

RELATED ARTICLES
Roche acquires Biocartis’ competitor

Roche has paid 190 million dollar for the acquisition of GeneWEAVE (Los Gatos, CA), an American company that specializes in molecular diagnostics.…


Bill & Melinda Gates Foundation fund University of Antwerp’s polio research

Gates wants to eradicate polio with the help of UAntwerpen. In the Western world, polio is no longer existent since a couple of decades. However, …

POPULAR TAGS

Japan pledges $130M to infectious disease fund

Written by LVS on in the category news with the tags , .


The Japanese government will invest an additional $130 million in the The Global Heath Innovative Technology (GHIT) Fund, which supports R&D on infectious diseases including malaria, tuberculosis, HIV and neglected tropical diseases.

The fund is a public-private partnership among seven Japanese pharmaceutical companies, the Japanese government, the Bill & Melinda Gates Foundation, the Wellcome Trust and the United Nations Development Program. The fund said it has invested more than $60 million in 60 development partnerships, and has started seven clinical trials in high-burden countries.

Japan's Ministry of Health, Labor and Welfare (MHLW) and Ministry of Foreign Affairs each pledged Y700 million ($7.2 million) to help launch the fund in 2013.

Adapted from BioCentury

Read more about: , .

RELATED ARTICLES
Roche acquires Biocartis’ competitor

Roche has paid 190 million dollar for the acquisition of GeneWEAVE (Los Gatos, CA), an American company that specializes in molecular diagnostics.…


Bill & Melinda Gates Foundation fund University of Antwerp’s polio research

Gates wants to eradicate polio with the help of UAntwerpen. In the Western world, polio is no longer existent since a couple of decades. However, …

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

V-Bio Ventures Itera Life Science KU Leuven Flanders.bio XpandInnovation Turnstone UGent GSK Biowin Janssen

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.